ロード中...
Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
BACKGROUND: Tumour budding (TB) and Tumour Stroma Ratio (TSR) may be rewarding in the treatment stratification of patients with stage II colon cancer. However, lack of standardization may exclude these parameters from being used in a clinical setting. The purpose of this methodologic study was to co...
保存先:
| 出版年: | Diagn Pathol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5859415/ https://ncbi.nlm.nih.gov/pubmed/29558947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-018-0697-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|